The Food and Drug Administration announced last week that the sleep drug Lunesta should be started at a lower dose.
CMS loosens nursing home infection control guidance for single-use devices
By
Tim Mullaney
May 13, 2014
Nursing homes now have new guidance about using certain types of reprocessed medical devices, the Centers for Medicare & Medicaid Services announced.
Supreme Court to hear case sparked by Omnicare deals
By
Julie Williamson
Apr 01, 2014
A recent $4 million legal settlement over kickbacks for anemia drug Aranesp is small change compared to other recent deals Omnicare has made with federal authorities. News of these payouts hasn’t...
FDA warning: Recalled rice product sold to nursing homes
By
Tim Mullaney
Feb 13, 2014
Nursing homes should ensure they are not serving potentially hazardous Uncle Ben’s brand rice products, the Food and Drug Administration has announced.
FDA hands down guidance on mobile apps
By
Elizabeth Newman
Dec 01, 2013
The Food and Drug Administration has issued final guidance on mobile medical apps.
Long-term care advocates denounce FDA over new hydrocodone restrictions
By
Tim Mullaney
Oct 28, 2013
The U.S. Food and Drug Administration has announced it will seek restricted access to hydrocodone painkillers, prompting a concerned response from long-term care stakeholders.
FDA approves Clinolipid for intravenous feeding
Oct 05, 2013
The Food and Drug Administration on Friday approved a lipid injectable emulsion called Clinolipid for parenteral nutrition in adult patients.
Long-term statin use reduces dementia risk by 30%, researchers discover
By
Tim Mullaney
Oct 02, 2013
Statins, which are commonly used to treat high cholesterol, do not cause cognition problems in the short term and may offer significant protection against dementia in the long term. This is according to...
Insulin infusion sets recalled
By
Elizabeth Newman
Jul 17, 2013
Certain Medtronic MiniMed Paradigm Insulin Infusion sets are being recalled, the Food and Drug Administration announced on Friday.
Two asthma inhalers left gasping for life
By
Elizabeth Newman
Jul 01, 2013
Two asthma inhalers are being phased out, the Food and Drug Administration announced at the end of May.